Moderna’s experimental mRNA flu shot will be reviewed by a Food and Drug Administration advisory panel next month, a move ...

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.

Moderna’s (MRNA) marketing application for its flu vaccine, mRNA-1010, will be reviewed by the FDA's independent experts next month, according to a federal notice posted on Thursday. The meeting of ...

The U.S. FDA said on Thursday it would hold a meeting of outside experts next ​month to review Moderna's experimental flu shot.

It's a sign that the agency may be increasing transparency into its decision-making after several controversies.

Learn more The open-session hearing comes just weeks ahead of the agency’s Aug. 5 target date to decide on the vaccine’s ...

Medical experts say that the best way to protect yourself and your family from the flu is by getting the vaccine, and now there's a new way for you to get vaccinated without a needle. This past flu ...

WASHINGTON — It’s time to get a flu vaccine, and pediatricians are urging people to get them after last winter, when the U.S. saw the most flu-related child deaths in 15 years. October is the ideal ...

CLEVELAND — As the respiratory virus season intensifies across Northeast Ohio, a Cleveland Clinic study from last flu season has sparked confusion about this year's vaccine. Dr. Steven Gordon, chair ...

By Sneha S K May 6 (Reuters) - Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, ...